Biotech IV Monitor

UTHR — United Therapeutics Corporation

$22.7B market cap · 7 upcoming readouts tracked

Clinical trial readout dates for United Therapeutics Corporation, compiled from ClinicalTrials.gov, alongside the SEC filings where results are announced. The next expected readout is December 2026.

Next readoutDecember 2026in ~1 month
Upcoming readouts74 Phase 3
Market cap$22.7B
Cash & investments$3.54Bas of Sep 30, 2026
Recent 8-K filings2latest 2026-11-04

Upcoming readouts

Phase 3 Ralinepag
PAH; Pulmonary Hypertension · NCT03683186
December 2026
Enrolling
Phase 3 Inhaled Treprostinil
Progressive Pulmonary Fibrosis; Interstitial Lung Disease · NCT05943535
November 2027
Recruiting
Phase 2 treprostinil SMI (treprostinil inhalation spray)
Pulmonary Hypertension Associated With Chronic Obstructive Pulmonary Disease · NCT07923591
May 2028
Not Yet Recruiting
Phase 1/2 10 GE Xenokidney
ESRD (End-Stage Renal Disease); Kidney Transplantation · NCT06878560
October 2028
Recruiting
Phase 1/2 GGTA1 KO Thymokidney
ESRD (End-Stage Renal Disease); Kidney Transplantation · NCT07224763
November 2029
Recruiting
Phase 3 Inhaled Treprostinil
Idiopathic Pulmonary Fibrosis; Interstitial Lung Disease · NCT04905693
December 2029
Enrolling
Phase 2/3 treprostinil SMI (treprostinil inhalation spray)
Pulmonary Hypertension Associated With Chronic Obstructive Pulmonary Disease · NCT07923526
September 2034
Not Yet Recruiting

Cash position

United Therapeutics Corporation reported $3.54B in cash, cash equivalents and marketable securities at Sep 30, 2026 (10-Q filed 2026-11-04). It reported net income of $259M for that quarter.

Recent SEC filings

8-K Results of Operations — earnings, may carry pipeline updates2026-11-04
8-K Other Events — often topline trial data2026-10-22

Companies working on similar indications

Discussion

No messages yet. If you follow UTHR, you can start the conversation.
Track UTHR in real time
See live implied volatility for UTHR and 106 other biotechs, and get alerted when a readout lands.
🔔 Alert me on UTHR
Contact — questions or corrections about UTHR: dukeupt@gmail.com